Cocrystal Pharma Stock Price on December 2, 2024
| COCP Stock | USD 3.09 0.61 24.60% |
Below is the normalized historical share price chart for Cocrystal Pharma extending back to April 01, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cocrystal Pharma stands at 3.09, as last reported on the 30th of December, with the highest price reaching 3.10 and the lowest price hitting 2.57 during the day.
If you're considering investing in Cocrystal Stock, it is important to understand the factors that can impact its price. Cocrystal Pharma is risky given 3 months investment horizon. Cocrystal Pharma secures Sharpe Ratio (or Efficiency) of 0.18, which signifies that the company had a 0.18% return per unit of standard deviation over the last 3 months. We were able to break down twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.13% are justified by taking the suggested risk. Use Cocrystal Pharma mean deviation of 3.94, and Risk Adjusted Performance of 0.1465 to evaluate company specific risk that cannot be diversified away.
At this time, Cocrystal Pharma's Total Stockholder Equity is relatively stable compared to the past year. As of 12/30/2024, Common Stock Total Equity is likely to grow to about 152.4 K, while Preferred Stock Total Equity is likely to drop slightly above 142.6 M. . As of 12/30/2024, Price To Sales Ratio is likely to drop to 382.56. In addition to that, Price Earnings Ratio is likely to drop to -0.97. Cocrystal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of May 2011 | 200 Day MA 1.9326 | 50 Day MA 2.0238 | Beta 1.445 |
Cocrystal |
Sharpe Ratio = 0.1759
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | COCP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.41 actual daily | 57 57% of assets are less volatile |
Expected Return
| 1.13 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 13 87% of assets perform better |
Based on monthly moving average Cocrystal Pharma is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cocrystal Pharma by adding it to a well-diversified portfolio.
Price Book 2.4748 | Enterprise Value Ebitda 0.661 | Price Sales 92.4548 | Shares Float 7 M | Wall Street Target Price 8 |
Related Headline
Monte Rosa Headline on 2nd of December 2024
The mean of analysts price targets for Monte Rosa Therapeutics points to a 64.1 percent upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Cocrystal Pharma Valuation on December 2, 2024
It is possible to determine the worth of Cocrystal Pharma on a given historical date. On December 2, 2024 Cocrystal was worth 2.06 at the beginning of the trading date compared to the closed value of 2.05. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cocrystal Pharma stock. Still, in general, we apply an absolute valuation method to find Cocrystal Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cocrystal Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cocrystal Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 2.11 | 2.11 | 1.97 | 2.07 | 4,056 | |
12/02/2024 | 2.06 | 2.13 | 2.02 | 2.05 | 14,527 |
| 2.13 | 2.13 | 2.00 | 2.00 | 23,173 |
| Backtest Cocrystal Pharma | | | Cocrystal Pharma History | | | Cocrystal Pharma Valuation | Previous | Next |
Cocrystal Pharma Trading Date Momentum on December 2, 2024
| On December 03 2024 Cocrystal Pharma was traded for 2.00 at the closing time. The top price for the day was 2.13 and the lowest listed price was 2.00 . The trading volume for the day was 23.2 K. The trading history from December 3, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.44% . The overall trading delta against the current closing price is 9.76% . |
Cocrystal Pharma Fundamentals Correlations and Trends
By evaluating Cocrystal Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cocrystal Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cocrystal financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cocrystal Pharma Stock history
Cocrystal Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cocrystal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cocrystal Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cocrystal Pharma stock prices may prove useful in developing a viable investing in Cocrystal Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 9.7 M | 13.1 M | |
| Net Loss | -35 M | -36.7 M |
Cocrystal Pharma Quarterly Net Working Capital |
|
Cocrystal Pharma Stock Technical Analysis
Cocrystal Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cocrystal Pharma Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Cocrystal Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cocrystal Pharma December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Cocrystal Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cocrystal Pharma shares will generate the highest return on investment. By undertsting and applying Cocrystal Pharma stock market strength indicators, traders can identify Cocrystal Pharma entry and exit signals to maximize returns
Cocrystal Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cocrystal Pharma's price direction in advance. Along with the technical and fundamental analysis of Cocrystal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cocrystal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1465 | |||
| Jensen Alpha | 1.08 | |||
| Total Risk Alpha | 0.9016 | |||
| Sortino Ratio | 0.3247 | |||
| Treynor Ratio | (5.63) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.